Thromboembolic events in polycythemia vera

por Griesshammer, Martin, Kiladjian, Jean-Jacques, Besses, Carlos
Publicado 2019

Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study

por Kiladjian, Jean-Jacques, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire, Coll, Ruth, Smith, Jonathan, Birgegård, Gunnar
Publicado 2012

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safe...

por Birgegård, Gunnar, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire N., Hamdani, Mohamed, Wu, Jingyang, Achenbach, Heinrich, Kiladjian, Jean-Jacques
Publicado 2018

Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients

por Gómez-Cebrián, Nuria, Rojas-Benedicto, Ayelén, Albors-Vaquer, Arturo, Bellosillo, Beatriz, Besses, Carlos, Martínez-López, Joaquín, Pineda-Lucena, Antonio, Puchades-Carrasco, Leonor
Publicado 2021

Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing

por Ferrer-Marín, Francisca, Bellosillo, Beatriz, Martínez-Avilés, Luz, Soler, Gloria, Carbonell, Pablo, Luengo-Gil, Ginés, Caparrós, Eva, Torregrosa, José M, Besses, Carlos, Vicente, Vicente
Publicado 2013